At the conclusion of this program, learners will share that they feel better prepared to manage patients presenting with headache conditions by applying best practices in Headache Medicine retailed to the diagnosis, epidemiology, and treatment of headache disorders in adults and children in clinical practice and research, and will consider the controversies and evidence for using CGRP antagonists during pregnancy, in patients with vascular risk factors and as combination therapies. Learners will report their intention to incorporate non-pharmacologic treatments in the management of migraine & select the appropriate neuroradiological investigations for various secondary headaches.
- Provider:American Headache Society
- Activity Link: https://cme.americanheadachesociety.org/node/425
- Start Date: 2024-11-14 06:00:00
- End Date: 2024-11-14 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 50.0 hours
- Commercial Support: Source: AbbVie - Amount: 0 - Is Kind Support: False Source: AbbVie - Amount: 45000.0 - Is Kind Support: False Source: Axsome Therapeutics - Amount: 25000.0 - Is Kind Support: False Source: Eli Lilly and Company - Amount: 35000.0 - Is Kind Support: False Source: Lundbeck - Amount: 65000.0 - Is Kind Support: False Source: Pfizer - Amount: 50000.0 - Is Kind Support: False
- Activity Type: Other/Blended Learning
- CME Finder Type: Other
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest